Abstract
Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Molecular and Immuno Oncology
Paper Title
Journal
Date